Real-World Long-Term Safety of Statin–Fibrate Combination Therapy in Older Patients (≥75 Years): A European Cohort Analysis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1A European, Observational, 3‐Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The <scp>POSE</scp> Study2024 · 4 citations
2. 2Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy2011 · 11 citations
3. 3Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence2014
4. 4Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis2026
5. 5Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study2019 · 96 citations